Cargando…
Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
BACKGROUND: In patients with major depressive disorder (MDD), antidepressant response and remission rates are low, highlighting the need for new treatment approaches. Recently, the abundant literature linking inflammatory processes and depressive symptoms have led to the hypothesis that selecting tr...
Autores principales: | Fourrier, Célia, Sampson, Emma, Mills, Natalie T., Baune, Bernhard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102899/ https://www.ncbi.nlm.nih.gov/pubmed/30126458 http://dx.doi.org/10.1186/s13063-018-2829-7 |
Ejemplares similares
-
Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
por: Mills, Natalie T, et al.
Publicado: (2020) -
Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial
por: Roberts, Seren Haf, et al.
Publicado: (2007) -
Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
por: McAllister-Williams, R Hamish, et al.
Publicado: (2013) -
Evaluating Augmented Depression Therapy (ADepT): study protocol for a pilot randomised controlled trial
por: Dunn, Barnaby D., et al.
Publicado: (2019) -
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
por: McIntyre, Roger S., et al.
Publicado: (2014)